Furthermore, previous studies have reported that silencing of Orai1 and Orai2 expression attenuate the Akt/mammalian target of rapamycin/NF-κB pathway in oral cancer cells, further supporting a role for Orai channels in NF-κB activation (29). Here, ORAI2 is linked to lip and oral cavity carcinoma.